Chemical Formula: C62H111N11O13
Chemical Formula C62H111N11O13
Found 29 metabolite its formula value is C62H111N11O13
Cyclosporin C
33-(1-hydroxy-2-methylhex-4-en-1-yl)-30-(1-hydroxyethyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
Cyclosporin metabolite m17
33-(1,6-dihydroxy-2-methylhex-4-en-1-yl)-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
Cyclosporin C
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-[(1R)-1-Hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotri-triacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
Cyclosporin C is a natural product found in Fusarium neocosmosporiellum, Trichoderma polysporum, and Gliomastix luzulae with data available.
Leucinostatin A
N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[[3-[1-(dimethylamino)propan-2-ylamino]-3-oxopropyl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-6-hydroxy-4-methyl-1,8-dioxodecan-2-yl]-4-methyl-1-[(E)-4-methylhex-2-enoyl]pyrrolidine-2-carboxamide
Correct chemical structure of Leucinostatin A was recently reported: Abe et. al. Catalytic Asymmetric Total Synthesis and Stereochemical Revision of Leucinostatin A: A Modulator of Tumor-Stroma Interaction, Chemistry A European Journal, 23, 11792-11796 (2017). DOI:10.1002/chem.201703239.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
(gamma-OH)MeLeu4-Cs|4-(gamma-hydroxymethylleucine)cyclosporin|[(4-OH)MeLeu]4-cyclosporin A|[(gamma-hydroxy)-NMeLeu]-4-cyclosporin|[gamma-hydroxy-MeLeu]4-cyclosporin
(gamma-OH)MeLeu4-Cs|4-(gamma-hydroxymethylleucine)cyclosporin|[(4-OH)MeLeu]4-cyclosporin A|[(gamma-hydroxy)-NMeLeu]-4-cyclosporin|[gamma-hydroxy-MeLeu]4-cyclosporin
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-[(1R)-1-hydroxyethyl]-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
Cyclosporine metabolite M17
33-[(E)-1,6-dihydroxy-2-methylhex-4-enyl]-30-ethyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins
Leucinostatin A M+H
Leucinostatin A M+H
D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides
(3S,6S,9S,12R,15S,18S,21S,24S,30S)-30-Ethyl-33-((E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl)-9-(2-hydroxy-2-methyl-propyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,18,24-tris(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
(3S,6S,9S,12R,15S,18S,21S,24S,30S)-30-Ethyl-33-((E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl)-9-(2-hydroxy-2-methyl-propyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,18,24-tris(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(2R,3R)-5-(2-hydroxyethyl)-3-methyltetrahydrofuran-2-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(2R,3R)-5-(2-hydroxyethyl)-3-methyltetrahydrofuran-2-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D003524 - Cyclosporins
(2S,4S)-N-[(2S,4S,6R)-1-[[(2S,3R)-1-[[1-[[(2S)-1-[[(2S)-1-[[1-[[1-[[3-[[(2S)-1-(dimethylamino)propan-2-yl]amino]-3-oxopropyl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-6-hydroxy-4-methyl-1,8-dioxodecan-2-yl]-4-methyl-1-[(E,4S)-4-methylhex-2-enoyl]pyrrolidine-2-carboxamide
(2S,4S)-N-[(2S,4S,6R)-1-[[(2S,3R)-1-[[1-[[(2S)-1-[[(2S)-1-[[1-[[1-[[3-[[(2S)-1-(dimethylamino)propan-2-yl]amino]-3-oxopropyl]amino]-2-methyl-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-3-hydroxy-4-methyl-1-oxopentan-2-yl]amino]-6-hydroxy-4-methyl-1,8-dioxodecan-2-yl]-4-methyl-1-[(E,4S)-4-methylhex-2-enoyl]pyrrolidine-2-carboxamide
cyclosporin A metabolite M1
cyclosporin A metabolite M1
A cyclosporin A derivative that is cyclosporin A in which residue 9 (N-methylleucine) has undergone oxidation so a to introduce a hydroxy group at the carbon bearing the two methyl groups.
cyclosporin A metabolite M17
cyclosporin A metabolite M17
A cyclosporin A derivative that is cyclosporin A in which residue 1 [(2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)oct-6-enoic acid] has undergone allylic oxidation to give the corresponding primary allylic alcohol. It specifically inhibits growth of renal cells in culture.
cyclosporin A metabolite M18
cyclosporin A metabolite M18
A cyclosporin A derivative that is cyclosporin A metabolite M17 in which the hydroxy group at position 3 of residue 1 [(2S,3R,4R,6E)-3,8-dihydroxy-4-methyl-2-(methylamino)oct-6-enamide] has undergone addition to the double bond at position 6 to afford the corresponding dioxolane ring.
(2s,4s,6r)-n-[(1s,2r)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4s)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(2s,4s,6r)-n-[(1s,2r)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4s)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(6s,9s,12s,15s,18s,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-6-[(1r)-1-hydroxyethyl]-12-isopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,30,33-pentakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone
(6s,9s,12s,15s,18s,21r,24s,27s,30s,33s)-8,17,23,26,32-pentahydroxy-9-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-6-[(1r)-1-hydroxyethyl]-12-isopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,30,33-pentakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone
(2s,4s)-n-[(1s,2r)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4r)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(2s,4s)-n-[(1s,2r)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4r)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
n-(1-{[1-({1-[(1-{[1-({1-[(2-{[1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]-3-methylbutyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-6-hydroxy-2-({hydroxy[4-methyl-1-(4-methylhex-2-enoyl)pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
n-(1-{[1-({1-[(1-{[1-({1-[(2-{[1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]-3-methylbutyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-6-hydroxy-2-({hydroxy[4-methyl-1-(4-methylhex-2-enoyl)pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(2s,4s,6s)-n-[(1s,2r)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4s)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(2s,4s,6s)-n-[(1s,2r)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4s)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
n-(1-{[1-({1-[(1-{[1-({1-[(2-{[1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]-3-methylbutyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-6-hydroxy-2-{[hydroxy({4-methyl-1-[(2e)-4-methylhex-2-enoyl]pyrrolidin-2-yl})methylidene]amino}-4-methyl-8-oxodecanimidic acid
n-(1-{[1-({1-[(1-{[1-({1-[(2-{[1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]-3-methylbutyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-6-hydroxy-2-{[hydroxy({4-methyl-1-[(2e)-4-methylhex-2-enoyl]pyrrolidin-2-yl})methylidene]amino}-4-methyl-8-oxodecanimidic acid
8,17,23,26,32-pentahydroxy-9-(1-hydroxy-2-methylhex-4-en-1-yl)-6-(1-hydroxyethyl)-12-isopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,30,33-pentakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone
8,17,23,26,32-pentahydroxy-9-(1-hydroxy-2-methylhex-4-en-1-yl)-6-(1-hydroxyethyl)-12-isopropyl-1,4,10,13,19,21,24,28-octamethyl-15,18,27,30,33-pentakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-7,16,22,25,31-pentaene-2,5,11,14,20,29-hexone
(3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-30-[(1r)-1-hydroxyethyl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone
(3s,6s,9s,12r,15s,18s,21s,24s,30s,33s)-14,17,23,32-tetrahydroxy-33-[(1r,2r,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-30-[(1r)-1-hydroxyethyl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone
14,17,23,32-tetrahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-30-(1-hydroxyethyl)-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone
14,17,23,32-tetrahydroxy-33-(1-hydroxy-2-methylhex-4-en-1-yl)-30-(1-hydroxyethyl)-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone
(3r,6s,9s,12r,15s,18s,21s,24s,30s,33r)-14,17,23,32-tetrahydroxy-33-[(1s,2s,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-30-[(1s)-1-hydroxyethyl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone
(3r,6s,9s,12r,15s,18s,21s,24s,30s,33r)-14,17,23,32-tetrahydroxy-33-[(1s,2s,4e)-1-hydroxy-2-methylhex-4-en-1-yl]-30-[(1s)-1-hydroxyethyl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone
(2s,4r,6s)-n-[(1s,2s)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4r)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(2s,4r,6s)-n-[(1s,2s)-1-[(1-{[(1s)-1-{[(1s)-1-{[1-({1-[(2-{[(2s)-1-(dimethylamino)propan-2-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]-1-methylethyl}-c-hydroxycarbonimidoyl)-1-methylethyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}-1-methylethyl)-c-hydroxycarbonimidoyl]-2-hydroxy-3-methylbutyl]-6-hydroxy-2-({hydroxy[(2s,4s)-4-methyl-1-[(2e,4r)-4-methylhex-2-enoyl]pyrrolidin-2-yl]methylidene}amino)-4-methyl-8-oxodecanimidic acid
(2S)-N-[(2S)-1-[[(E,3S)-4-[(2S,3R)-2-amino-3-hydroxybutanoyl]-4-[(3S,8S)-6-[(2R)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]-2,5,10-trimethyl-3-(methylamino)-8-[[(2S)-4-methyl-2-(methylamino)pentanoyl]amino]-4,7-dioxoundec-10-en-5-yl]-3-formyl-7-hydroxy-8-methyl-1,6-bis(methylamino)-2,5-dioxododec-10-en-3-yl]-methylamino]-4-methyl-1-oxopentan-2-yl]-4-methyl-2-(methylamino)pentanamide
(2S)-N-[(2S)-1-[[(E,3S)-4-[(2S,3R)-2-amino-3-hydroxybutanoyl]-4-[(3S,8S)-6-[(2R)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]-2,5,10-trimethyl-3-(methylamino)-8-[[(2S)-4-methyl-2-(methylamino)pentanoyl]amino]-4,7-dioxoundec-10-en-5-yl]-3-formyl-7-hydroxy-8-methyl-1,6-bis(methylamino)-2,5-dioxododec-10-en-3-yl]-methylamino]-4-methyl-1-oxopentan-2-yl]-4-methyl-2-(methylamino)pentanamide
